facebook

ASK Select

Scheme Rating

IME Scheme Rating

3 of 5 stars

Prefer other ASK Strategies: For investors looking for a concentrated portfolio, ASK India Select offers a concentrated strategy with one of the most established teams in the industry. However, we prefer ASK IEP & ASK Growth, given their more consistent longer-term returns.

IME Strategy Rating

4 of 5 stars

Concentrated Top-Ideas Portfolio: Invests in top value-creation ideas identified across more tightly defined strategies. The portfolio maintains a blend of opportunity size, earnings growth, business quality, and price-value gap; with a reasonably concentrated (20 stocks) portfolio. With a 10+ years track record, ASK – India Select has established its credibility by navigating through various market phases and consistently delivering above par returns.

PMS Scheme Ratings are driven by IME’s Proprietary Scheme Rating Methodology, which takes into account our ratings of the Scheme’s investment strategy, its maturity, the investment team, and our separate rating on the AMC that runs this particular scheme. Our views on each of these individual criteria are available via the IME RMS – which you can view by reaching out to one of our relationship managers (using either the live chat or book appointment feature on this site).

IME View on ASK Select

Type: Large & Midcap | GARP | AUM (2532.1 cr) | Inc Date (4 Jan 2010)

ASK India Select - Investment Strategy

Concentrated exposure to the ASK's top value-creation investment opportunities.

ASK’s India Select Portfolio invests in the top value-creation ideas that ASK has identified across other more tightly defined strategies. The portfolio tries to maintain a blend between the size of the opportunity, earnings growth, business quality, and the price-value gap.

Key Investment Attributes

Investments in ASK India Select Portfolio are driven by the following key investment attributes:

  • Size of Opportunity: Size of Pond vs. Size of Fish, Dominance, Resilience, Liquidity
  • Quality of Business: High quality of business (superior ROCE), Strong moat, Impregnability, Sustainability, Key pivot of strong wealth creation 
  • Earnings Growth: Quantum, Consistency, Durability, Predating (early vs later), Compounding power
  • Value: Favourable price-value gap, Margin of Safety
  • Management Quality: Good management quality is a given constant

Investment Process

The investment process is driven by a gradual filtering down of companies in a wider universe, based on specific criteria that ASK focuses on:

  • 500: Start with top 500 as per mkt cap 
  • 410: PBT above 75 cr for the trailing 4 quarters
  • 206: Subjective evaluation of management quality (integrity, vision, execution, capital allocation and capital distribution)
  • 92: Rigorous filters of minimum of 20% of ROCE (capital efficiency) and min of 15% annual earnings growth over the next 3 to 5 years
  • 20: Finally an investment approach emerges of 20 businesses, representing an optimal blend of the overall characteristics, and adequate diversity, with a minimum margin of safety of 15%

Trailing Performance

1yr 3yr 5yr Since Inception
ASK Select 30.3 10.5 16.8 16.3
S&P BSE 500 TRI 41.1 18.9 22.9 13.8
Alpha over Broad Mkt BM -10.8 -8.4 -6.1 2.5
Nifty 500 40.2 17.7 21.5
Alpha over Category BM -9.9 -7.2 -4.7

Performance as of: 31-Aug-24 | Inception Date: 04-Jan-10

Fund Managers

Sandip Bansal | 4-star rated FM

Senior Portfolio Manager | 21 yrs Experience | 3 yrs at current firm

Past Experience: FM & Head Investment Research (SBI Life), Sell-side Research Analyst (UBS, KIE)

Sandip has 18 years of work experiene (14 of which have been in equity research). Sandip has a strong research & fund management experience, having worked as Fund Manager & Head of Research at SBI Life Insurance prior to joining ASK. Prior to SBI Life, Sandip worked at the sell side with UBS & KOtak Securities. Sandip in a CA and an MBA (IIM-A)

Fee Structure

Fee StructureFee
Fixed Fee Structure2.5
Variable Fee Structures1.5% fixed + 20% above 8% hurdle
Exit Fees

AMC

AMC: ASK PMS (click link for detailed AMC review)

Highly recommended for more conservative investors: ASK has a number of positives, which has led to them becoming the market leader. Strict adherence to a clearly defined investment policy, along with a strong & stable in-house grown investment team, is what helps set them apart and deliver consistent and attractive long-term returns. The majority stake (75%) of ASK's asset management business was acquired by Blackstone in Feb-22. We have recently downgraded ASK's rating to 4-star, keeping in mind the sharp underperfomance since 2022 (which we believe should be transitory in nature). As performance comes back, ASK's rating could be upgraded to a 5-star.

AMC Rating

4 of 5 stars

AMC Pedigree

5 of 5 stars

AMC Size

5 of 5 stars

Team Pedigree

5 of 5 stars

Inv Philosophy

5 of 5 stars

Performance

3 of 5 stars

Free 30-Day Trial of the IME RMS

Details shared above, are only a short-snapshot of the more detailed analysis that resides in IME’s Proprietary RMS (Research Management Solution).

The IME RMS is the first tool ever, to give investors direct access to the insights of the central research team. Investors gain direct access to our ratings, rating rationales & analysis across thousands of funds (MFs, PMSs, AIFs, Global funds), asset classes, categories & more.

 Learn More

IME RMS Demo

Register 30-Day Trial

Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.

CONNECT WITH US

Use our Live Chat
Book 15-min Introductory Call
WhatsApp us @ +91 96320 07774

IME Capital Pvt. Ltd. is a research-first investments firm. We aim to disrupt the wealth management industry, by shrinking the gap in investment insights between central research teams & RMs/Clients. 

Products
Solutions
Disclaimer MF/PMS/AIF/Direct Equities are all subject to market risks. Please read the scheme information and other related documents carefully prior to investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund or designing a portfolio that suits your needs. Market & other data on this site has been sourced from what are considered to be reliable sources. All views shared (product ratings, views on individual securities etc.) are the proprietary property of IME Capital and cannot be used in any form without explicit written consent. IME Capital Pvt. Ltd. makes no warranties or representations, express or implied, on products offered through the platform (and that of our partners) or on the correctness of data & views shared. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Detailed Disclaimer © 2021 All rights reserved | ARN No: ARN-182445